Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$584M |
| 2 |
Pfizer
PFE
|
+$343M |
| 3 |
WCN
Waste Connections
WCN
|
+$320M |
| 4 |
American Express
AXP
|
+$294M |
| 5 |
Universal Health Services
UHS
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$213M |
| 2 |
Newell Brands
NWL
|
+$185M |
| 3 |
Adobe
ADBE
|
+$177M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$161M |
| 5 |
UnitedHealth
UNH
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.49% |
| 2 | Healthcare | 19.14% |
| 3 | Industrials | 16.44% |
| 4 | Communication Services | 11.2% |
| 5 | Consumer Staples | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$160B
| $649M | 8.81% |
19,421,872
+10,745,025
| +124% | +$343M |
|
|
2
Philip Morris
PM
$293B
| $595M | 8.08% |
+5,851,537
| New | +$584M |
|
3
Sabre
SABR
$848M
| $531M | 7.21% |
19,820,738
+4,710,522
| +31% | +$132M |
|
|
VISN
4
Vistance Networks Inc
VISN
$2.59B
| $473M | 6.42% |
15,242,742
+1,764,314
| +13% | +$52.4M |
|
5
Booking.com
BKNG
$158B
| $470M | 6.38% |
9,410,475
+2,845,175
| +43% | +$148M |
|
6
Lam Research
LRCX
$393B
| $459M | 6.24% |
54,655,490
+24,895,470
| +84% | +$200M |
|
|
WCN
7
Waste Connections
WCN
$42.6B
| $400M | 5.43% |
8,326,604
+7,042,910
| +549% | +$320M |
|
|
8
Universal Health Services
UHS
$10.4B
| $371M | 5.04% |
2,768,938
+1,802,394
| +186% | +$238M |
|
9
Meta Platforms (Facebook)
META
$1.4T
| $318M | 4.31% |
2,780,705
+1,184,327
| +74% | +$136M |
|
|
10
American Express
AXP
$227B
| $282M | 3.83% |
4,646,790
+4,637,950
| +52,465% | +$294M |
|
11
Northrop Grumman
NOC
$78.3B
| $259M | 3.52% |
1,166,696
+508,078
| +77% | +$107M |
|
|
12
Adobe
ADBE
$109B
| $246M | 3.34% |
2,572,317
-1,838,296
| -42% | -$177M |
|
13
Aramark
ARMK
$15.8B
| $227M | 3.08% |
9,393,312
-5,681,979
| -38% | -$137M |
|
14
Comcast
CMCSA
$95.3B
| $219M | 2.97% |
6,718,516
+3,258,520
| +94% | +$101M |
|
15
TransDigm Group
TDG
$66.4B
| $211M | 2.86% |
800,192
-192,407
| -19% | -$47M |
|
16
Alphabet (Google) Class C
GOOG
$4.18T
| $203M | 2.76% |
5,879,740
-530,220
| -8% | -$19M |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $203M | 2.75% |
878,319
-532,043
| -38% | -$123M |
|
|
CSC
18
DELISTED
Computer Sciences
CSC
| $152M | 2.06% |
+3,060,018
| New | +$124M |
|
19
US Bancorp
USB
$96.7B
| $146M | 1.98% |
3,615,569
+2,625,458
| +265% | +$109M |
|
20
Radian Group
RDN
$4.84B
| $145M | 1.97% |
13,941,442
-2,738,899
| -16% | -$32.2M |
|
21
Viatris
VTRS
$18.7B
| $99.2M | 1.35% |
+2,294,698
| New | +$102M |
|
22
AB InBev
BUD
$155B
| $83.1M | 1.13% |
630,713
-607,850
| -49% | -$76.5M |
|
|
23
Newell Brands
NWL
$2.59B
| $69.9M | 0.95% |
1,440,115
-3,958,988
| -73% | -$185M |
|
24
Jack in the Box
JACK
$331M
| $57.3M | 0.78% |
+666,861
| New | +$50.3M |
|
25
Pacific Biosciences
PACB
$420M
| $55M | 0.75% |
7,820,808
+259,540
| +3% | +$2.37M |
|
Similar funds
Lee Ainslie's Q2 2016 Portfolio in Review
As of Q2 2016, Lee Ainslie held 164 positions worth $7.37B, up 17% from $6.32B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Lee Ainslie deployed $903M of net new capital in Q2 2016, opening 32 new positions and adding to 76 existing holdings. Its largest new stake was Philip Morris: 5,851,537 shares worth $595M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Liberty Global Class C, an estimated $213M trimmed.
- Lee Ainslie's largest Q2 2016 buy was Philip Morris: 5,851,537 shares worth $595M.
- Lee Ainslie added most to Pfizer in Q2 2016, an estimated $343M increase.
- Lee Ainslie's biggest Q2 2016 reduction was Liberty Global Class C, cutting an estimated $213M.
- Lee Ainslie fully exited Sensata Technologies in Q2 2016, selling an estimated $137M.
- Lee Ainslie's ten largest holdings make up 62% of its $7.37B portfolio in Q2 2016.
- Lee Ainslie opened 32 new positions and closed 32 in Q2 2016.
- Lee Ainslie's portfolio value rose 17% quarter-over-quarter to $7.37B.
Based on Maverick Capital's 13F filing for Q2 2016, filed 15 Aug 2016.